Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors

被引:57
作者
Cernak, Tim [1 ]
Gesmundo, Nathan J. [1 ]
Dykstra, Kevin [1 ]
Yu, Yang [1 ]
Wu, Zhicai [1 ]
Shi, Zhi-Cai [1 ]
Vachal, Petr [1 ]
Sperbeck, Donald [1 ]
He, Shuwen [1 ]
Murphy, Beth Ann [1 ]
Sonatore, Lisa [1 ]
Williams, Steven [1 ]
Madeira, Maria [1 ]
Verras, Andreas [1 ]
Reiter, Maud [1 ]
Lee, Claire Heechoon [1 ]
Cuff, James [1 ]
Sherer, Edward C. [1 ]
Kuethe, Jeffrey [1 ]
Goble, Stephen [1 ]
Perrotto, Nicholas [1 ]
Pinto, Shirly [1 ]
Shen, Dong-Ming [1 ]
Nargund, Ravi [1 ]
Balkovec, James [1 ]
DeVita, Robert J. [1 ]
Dreher, Spencer D. [1 ]
机构
[1] Merck & Co Inc, MRL, Dept Discovery Chem, Rahway, NJ 07065 USA
关键词
LATE-STAGE FUNCTIONALIZATION; MEDICINAL CHEMISTS TOOLBOX; DGAT1; INHIBITORS; ARYL CHLORIDES; HYDROGENATION; OPTIMIZATION; MECHANISM; BASE;
D O I
10.1021/acs.jmedchem.6b01543
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Miniaturization and parallel processing play an important role in the evolution of many technologies. We demonstrate the application of miniaturized high-throughput experimentation methods to resolve synthetic chemistry challenges on the frontlines of a lead optimization effort to develop diacylglycerol acyltransferase (DGAT1) inhibitors. Reactions were performed on similar to 1 mg scale using glass microvials providing a miniaturized high-throughput experimentation capability that was used to study a challenging SNAr reaction. The availability of robust synthetic chemistry conditions discovered in these miniaturized investigations enabled the development of structure-activity relationships that ultimately led to the discovery of soluble, selective, and potent inhibitors of DGAT1.
引用
收藏
页码:3594 / 3605
页数:12
相关论文
共 51 条
[1]   Making medicinal chemistry more effective-application of Lean Sigma to improve processes, speed and quality [J].
Andersson, Shalini ;
Armstrong, Alan ;
Bjore, Annika ;
Bowker, Sue ;
Chapman, Steve ;
Davies, Rob ;
Donald, Craig ;
Egner, Bryan ;
Elebring, Thomas ;
Holmqvist, Sara ;
Inghardt, Tord ;
Johannesson, Petra ;
Johansson, Magnus ;
Johnstone, Craig ;
Kemmitt, Paul ;
Kihlberg, Jan ;
Korsgren, Pernilla ;
Lemurell, Malin ;
Moore, Jane ;
Pettersson, Jonas A. ;
Pointon, Helen ;
Ponten, Fritiof ;
Schofield, Paul ;
Selmi, Nidhal ;
Whittamore, Paul .
DRUG DISCOVERY TODAY, 2009, 14 (11-12) :598-604
[2]  
[Anonymous], 2012, J CLIN LIPIDOL, DOI [10.1016/j.jacl.2012.04.034, DOI 10.1016/J.JACL.2012.04.034]
[3]  
Beaulieu PL, 2003, SYNTHESIS-STUTTGART, P1683
[4]   Rapid Catalyst Identification for the Synthesis of the Pyrimidinone Core of HIV Integrase Inhibitors [J].
Bellomo, Ana ;
Celebi-Olcum, Nihan ;
Bu, Xiaodong ;
Rivera, Nelo ;
Ruck, Rebecca T. ;
Welch, Christopher J. ;
Houk, Kendall N. ;
Dreher, Spencer D. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (28) :6912-6915
[5]  
Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489
[6]  
Brown D. G., 2016, J MED CHEM, V59, P4443
[7]   Pharmaceutical Process Chemistry: Evolution of a Contemporary Data-Rich Laboratory Environment [J].
Caron, Stephane ;
Thomson, Nicholas M. .
JOURNAL OF ORGANIC CHEMISTRY, 2015, 80 (06) :2943-2958
[8]  
CERNAK T, 2016, CHEM, V1
[9]   The medicinal chemist's toolbox for late stage functionalization of drug-like molecules [J].
Cernak, Tim ;
Dykstra, Kevin D. ;
Tyagarajan, Sriram ;
Vachal, Petr ;
Krska, Shane W. .
CHEMICAL SOCIETY REVIEWS, 2016, 45 (03) :546-576
[10]   Synthesis of oxaspiropiperidines as a strategy for lowering log D [J].
Cernak, Timothy ;
Dykstra, Kevin ;
Levorse, Dorothy ;
Verras, Andreas ;
Balkovec, James ;
Nargund, Ravi ;
DeVita, Robert .
TETRAHEDRON LETTERS, 2011, 52 (48) :6457-6459